[This review was originally posted at the Nieman Journalism Lab Bactrim No Rx, on Feb. 25, 2011.]
The short, happy-ish life of TBD: Just six months after it launched and two weeks after a reorganization was announced, the Washington, D.C., local news site was effectively shuttered this week, where can i buy cheapest Bactrim online, when its corporate parent, Allbritton Communications (it's owned by Robert Allbritton and includes Politico), cut all of its jobs, leaving only an arts and entertainment operation within the website of Allbritton's WJLA-TV.
TBD had been seen many as a bellwether in online-only local news, After Bactrim, as Poynter's Mallary Jean Tenore documented in her historical roundup of links about the site, so it was quite a shock and a disappointment to many future-of-newsies that it was closed so quickly. The response — aptly compiled by TBDer Jeff Sonderman — was largely sympathetic to TBD's staff (former TBD manager Jim Brady even wrote a pitch to prospective employers on behalf of the newly laid off community engagement team). Many observers on Twitter (and Terry Heaton on his blog) pointed squarely at Allbritton for the site's demise, with The Batavian's Howard Owens drawing out a short, thoughtful lesson: "Legacy managers will nearly always sabotage innovation. Wall of separation necessary between innovators and legacy."
Blogger Mike Clark pointed out that TBD's traffic was beating each of the other D.C. TV news sites and growing as well, Bactrim No Rx. The Washington Post reported that while traffic wasn't a problem, Bactrim blogs, turning it into revenue was — though the fact that TBD's ads were handled by WJLA staffers might have contributed to that.
Mallary Jean Tenore wrote an insightful article talking to some TBD folks about whether their company gave them a chance to fail. Lehigh j-prof Jeremy Littau was unequivocal on the subject: "Some of us have been talking today on Twitter about whether TBD failed. Nonsense. TBD wasn’t given enough time to fail."
While CUNY j-prof Jeff Jarvis lamented Bactrim No Rx, that "TBD will be painted as a failure of local news online when it's a failure of its company, nothing more," others saw some larger implications for other online local news projects. Media analyst Alan Mutter concluded that TBD's plight is "further evidence that hyperlocal journalism is more hype than hope for the news business, Order Bactrim from United States pharmacy, " and Poynter's Rick Edmonds gave six business lessons for similar projects from TBD's struggles. Journal Register Co. CEO John Paton ripped Edmonds' analysis, arguing that Allbritton "can’t pretend to have seriously tried the hyperlocal business space after a six-month experiment it derailed half-way in."
Applying Apple's new rules: Publishers' consternation over Apple's new subscription plan for mobile devices continued this week, with Frederic Filloux at Monday Note laying out many publishers' frustrations with Apple's proposal. The New York Times' David Carr and The Guardian's Josh Halliday both covered publishers' Apple subscription conundrum, and one expert told Carr, Bactrim over the counter, "If you are a publisher, it puts things into a tailspin: The business model you have been working with for many years just lost 30 percent off the top."
At paidContent, James McQuivey made the case for a lower revenue share for Apple, and Dan Gillmor wondered whether publishers will stand up to Apple. The company may also be facing scrutiny from the U.S, Bactrim No Rx. Justice Department and Federal Trade Commission for possible antitrust violations, Buy Bactrim without a prescription, The Wall Street Journal reported.
The fresh issue regarding Apple's subscription policy this week, though, was the distinction between publishing apps and more service-oriented apps. The topic came to the fore when the folks from Readability, an app that allows users to read articles in an advertising-free environment, wrote an open letter ripping Apple for rejecting their app, buying Bactrim online over the counter, saying their new policy "smacks of greed." Ars Technica's Chris Foresman and Apple blogger John Gruber noted, though, that Readability's 30%-off-the-top business model is a lot like Apple's.
Then Apple's Steve Jobs sent a short, cryptic email to a developer saying that Apple's new policy applies only to publishing apps, Rx free Bactrim, not service apps. Bactrim No Rx, This, of course, raised the question, in TechCrunch's words, "What's a publishing app?" That's a very complex question, and as Instapaper founder Marco Arment wrote, one that will be difficult for Apple to answer consistently. Arment also briefly noted that Jobs' statement seems to contradict the language of Apple's new guidelines.
Giving voice to new sources of news: This month's Carnival of Journalism, posted late last week, focused on ways to increase the number of news sources. It's a broad question, and it drew a broad variety of answers, Bactrim schedule, which were ably summarized by Courtney Shove. I'm not going to try to duplicate her work here, but I do want to highlight a few of the themes that showed up.
David Cohn, the Carnival's organizer, gave a great big-picture perspective to the issue, putting it in the context of power and the web. Kim Bui and Dan Fenster defended the community-driven vision for news, with Bui calling journalists to go further: "Let’s admit it, we’ve never trusted the public." There were several calls for journalists to include more underrepresented voices, with reports and ideas like a refugee news initiative, digital news bus, youth journalism projects, and initiatives for youth in foreign-language families, Bactrim No Rx.
The J-Lab's Jan Schaffer gave 10 good ideas to the cause, and Drury j-prof Jonathan Groves and Gannett's Ryan Sholin shared their ideas for local citizen news projects, Bactrim australia, uk, us, usa, while TheUpTake's Jason Barnett endorsed a new citizen-journalism app called iBreakNews.
Three bloggers, however, objected to the Carnival's premise in the first place. Daniel Bachhuber of CUNY argued that improving journalism doesn't necessarily mean adding more sources, recommending instead that "Instead of increasing the number of news sources, we should focus on producing durable data and the equivalent tools for remixing it." Lauren Rabaino warned against news oversaturation, order Bactrim no prescription, and the University of Colorado's Steve Outing said that more than new sources, we need better filters and hubs for them.
Blogging's continued evolution: The "blogging is dead" argument has popped up from time to time, and it was revived again this week in the form of a New York Times story about how young people are leaving blogs for social networking sites like Facebook and Twitter. Bactrim No Rx, Several people countered the argument, led by GigaOM's Mathew Ingram, who said that blogging isn't declining, but is instead evolving into more of a continuum that includes microblogging services like Twitter, traditional blog formats like Wordpress, and the hybrid that is Tumblr. He and Wordpress founding developer Matt Mullenweg shared the same view — that "people of all ages are becoming more and more comfortable publishing online," no matter the form.
Scott Rosenberg, who's written a history of blogging, looked at statistics to make the point, noting that 14% of online adults keep a blog, buy Bactrim online no prescription, a number he called astounding, even if it starts to decline. "As the online population becomes closer to universal, that is an extraordinary thing: One in ten people writing in public. Our civilization has never seen anything like it." In addition, Bactrim treatment, Reuters' Anthony DeRosa argued that longer-form blogging has always been a pursuit of older Internet users.
Reading roundup: I've got a few ongoing stories to update you on, and a sampling of an unusually rich week in thoughtful pieces.
— A couple of sites took a peek at Gawker's traffic statistics to try to determine the effectiveness of its recent redesign, Bactrim No Rx. TechCrunch saw an ugly picture; Business Insider was cautiously optimistic based on the same data. Gawker disputed TechCrunch's numbers, and Terry Heaton tried to sort through the claims.
— A couple of Middle East/North Africa protest notes: The New York Times told us about the response to Egypt's Internet blackout and the role of mobile technology in documenting the protests, is Bactrim safe. And Amy Gahran of the Knight Digital Media Center gave some lessons from the incredible Twitter journalism of NPR's Andy Carvin.
— The Daily is coming to Android tablets Bactrim No Rx, this spring, and its free trial run has been extended beyond the initial two weeks.
— Matt DeRienzo of the Journal Register Co. wrote about an intriguing idea for a news org/j-school merger.
— Alan Mutter made the case for ending federal funding for public journalism.
— At 10,000 Words, Lauren Rabaino had some awesome things news organizations can learn from tech startups, including thinking of news as software and embracing transparency.
— And here at the Lab, Northwestern prof Pablo Boczkowski gave some quick thoughts on how we tend to associate online news with work, and what that means. He sheds some light about an under-considered aspect of news — the social environments in which we consume it.
Similar posts: Retin A No Rx. Flagyl No Rx. Armour For Sale. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Bactrim No Rx. Bactrim No Rx. Bactrim No Rx. Bactrim coupon. Bactrim from canada. Online Bactrim without a prescription.
[This review was originally posted at the Nieman Journalism Lab Glucophage Price, on Feb. 11, 2011.]
AOL scoops up Arianna: The week's biggest media story was broken just a couple of hours after the Super Bowl on Sunday, when Kara Swisher of All Things D reported that AOL would buy The Huffington Post for $315 million (here's video of her interview with Arianna Huffington and AOL CEO Tim Armstrong). Swisher's post and this New York Times article provide just about all the background information you should need on the deal, along with The Huffington Post's press release and Huffington's column on the acquisition. Glucophage canada, mexico, india, The deal was seen by many as a bold one — a "fourth-quarter Hail Mary pass," as The New Yorker's Ken Auletta wrote — and reaction on the web (also summed up well by GigaOM's Mathew Ingram) was decidedly mixed. The thumbs-ups came from a eclectic mix of critics: Henry Blodget of Business Insider called it a smart risk, Reuters' Felix Salmon and All Things D's Peter Kafka said the two companies' needs fit each other well, with AOL getting a clear editorial voice (Salmon) and a "content-making machine" (Kafka). CUNY j-prof Jeff Jarvis said what AOL will find most valuable in HuffPo will not be content, but "a new cultural understanding of media that is built around the value of curation, the power of peers, the link economy, passion as an asset, and celebrity as a currency."
There were also plenty of people who shook (or at least scratched) their heads at the deal, including many of HuffPo's own readers and writers, Glucophage Price. Shira Ovide of The Wall Street Journal called it AOL's admission that its content strategy isn't working, and industry analyst Alan Mutter said AOL overpaid, online buy Glucophage without a prescription. The Guardian's Jemima Kiss blasted the move as "soullessly commercial," and Salon vet Scott Rosenberg contended that Huffington's once-distinctive brand will dissolve into AOL's bland corporatism. PaidContent's David Kaplan, Dan Lyons, and Om Malik of GigaOM both pointed to advertising struggles, Discount Glucophage, with Malik arguing that AOL has "not yet come to terms with the futility of chasing page views."
A few themes came up repeatedly in commentary about the two companies; one was HuffPo's expertise in that notorious (some would say dark) art known as search engine optimization. Salon's Alex Pareene declared the new organization "the single largest SEO-gaming operation ever created" and the LA Times' James Rainey explained the appeal that the Post's SEO skills bring. Slate's Farhad Manjoo (who wins this week's award for best lead) made the case that AOL/HuffPo's SEO-heavy strategy is risky in the long-term because "they won't be able to fool the computers forever." (Capital New York's Tom McGeveran made a similar point Glucophage Price, .) HuffPo's new AOL corporate empire-mate, Paul Carr of TechCrunch, reaffirmed his hatred for HuffPo's SEO tactics but said the deal could still be a good one for AOL.
The second theme was the fact that the Post doesn't pay most of its writers, a strategy that Tim Rutten of the Los Angeles Times likened to "a galley rowed by slaves and commanded by pirates." Dan Gillmor's tone was a bit milder, but he, Glucophage samples, too, urged Huffington to start paying her most productive bloggers, and Northeastern j-prof Dan Kennedy wondered whether bloggers might be less willing to go unpaid under a mega-corporation like AOL. Reason's Matt Welch defended Huffington against Rutten's charges, and Time's James Poniewozik said it's possible AOL/HuffPo could be signaling a move toward more expensive, Australia, uk, us, usa, quality content.
A few miscellaneous pieces of sharp commentary: GigaOM's Mathew Ingram said AOL needs HuffPo to help its other online content initatives figure out how the Internet works, and media analyst Ken Doctor saw AOL/HuffPo as a potential free alternative to Rupert Murdoch's steadily building paid-content empire. There were also plenty of posts about what the political viewpoint of the new organization would be, and while I haven't waded into that discussion, I do like NYU j-prof Jay Rosen's concept of "ideological innovation" in online journalism.
Changing coverage of a changing world: As the protests in Egypt have continued, so has the conversation about its media-related implications, and just as in last week, much of the talk centered on Al Jazeera, Glucophage Price. The New York Times examined the network's influence on the protests, Glucophage natural, as well as its efforts to gain more access to American viewers. Throughout the past two weeks, as the Lab's Justin Ellis and Twitter's Robin Sloan pointed out, Al Jazeera has been using social media to distribute its news to American audiences. Meanwhile, Glucophage overnight, Sheila Carapico at Foreign Policy argued that Al Jazeera and other TV networks can't give us a full picture of what's going on in Egypt.
There's been other fantastic journalism arising from the Egyptian protests, including the work of NPR's Andy Carvin to curate news and voices of the conflict on Twitter. Glucophage Price, In an illuminating interview with The Atlantic, Carvin argued that curation — the process of capturing the most elements of a story from various sources and passing them along — has always been a part of journalism. In a more academic piece at the Lab, USC grad student Nikki Usher explained how the protests are expanding the idea of a media event, with social media, webstreams, Glucophage cost, and the mainstream media "all working together to create a much larger, more nuanced picture of the live broadcasting of history."
The debate over social media's role in revolutions continued to roil, with several more writers responding to Malcolm Gladwell's brief New Yorker post arguing that the role Twitter & Co. in social activism like the Egyptian protests is overrated. UT-Dallas prof David Parry, Glucophage images, The Awl's Maria Bustillos, new media exec Rex Hammock, UMBC prof Zeynek Tufekci, and web philosopher David Weinbergerall weighed in with their rejoinders to Gladwell, in a discussion that Washington grad student Deen Freelon has mapped out far more expertly than I could.
Speeding up The Daily: The negative buzz around The Daily that began last week continued to pile up this week, leading to, Glucophage use, among other things, a "We're listening" blog post by the new "tablet newspaper." One of the issues that drew criticism was The Daily's long load time, as John Gruber of Daring Fireball compared it unfavorably to Flipboard, and paidContent's Staci Kramer explained her own loading glitches. Both Gruber and Kramer argued that while it seem minor, load time is a big deal to users, and The New York Times' Nick Bilton made a similar point: By being too slow and bulky, digital magazines like The Daily "almost defeat one of their main intended purposes, the promise of instant access to content and information."
The reviews kept pouring in as well, led by an insightful critique of The Daily's design by Stephen Coles at Fonts In Use, Glucophage Price. The primary criticism continued in the same vein as last week: The Daily's content just doesn't cut it. John Gapper of the Financial Times and Skip Ferderber of Crosscut made the point this week, Glucophage wiki, and Poynter's Damon Kiesow noted that new content is tough to find. Paul Davis of Shareable also chimed in with a criticism of The Daily's shortcomings with limited sharing options.
But there were a few who were generally impressed with The Daily's first week, including MinnPost's John Dreinan and industry analyst Alan Mutter, who liked its concise storytelling, multimedia integration and interactive advertising. Damon Kiesow and The Columbia Journalism Review's Lauren Kirchner both looked to other media efforts for lessons for The Daily — Kiesow to various other iPad apps, and Kirchner to the mid-1990s debut of Slate and Salon, Glucophage no prescription.
Gawker evolves the blog: We've been hearing about it since November, and this week Gawker officially launched its redesign, which reflects to a more magazine-style emphasis from a purer blog format. The Lab's Megan Garber captured what the move means Glucophage Price, particularly in terms of Gawker's advertising strategy, explaining how it's appropriated parts of the TV and magazine models to capitalize on its brand as a whole: "It’s moved, it seems, beyond simply selling its readers to advertisers. Now, it is simply selling itself."
Former Gawker Media contributor Latoya Peterson pointed to the outrage by Gawker blogs' readers and used it to argue that Gawker's new, My Glucophage experience, more controlled design is subverting the fast-posting, skim-friendly style it helped make a blogging standard. Rex Sorgatz was also skeptical of the change, asserting that the redesign would have to be rolled back or reworked within months and challenging anyone to bet him otherwise — a wager that was taken up by Gawker chief Nick Denton himself, using pageviews as the determining factor.
TBD takes a step back: TBD, a online local news operation based in Washington, real brand Glucophage online, D.C., debuted last August to much fanfare, but it took a major hit when the Washington Post reported that its owner Robert Allbritton (who also owns Politico) would have his local TV station WJLA take it over. TBD editor-in-chief Erik Wemple told the Lab's Megan Garber that the move wouldn't be as bad as it appeared, but it was still widely interpreted as "a retreat from the original vision of TBD, Purchase Glucophage online no prescription, " in the Post's words. Jim Brady, the site's former general manager, called it "not good news," and NYU j-prof Jay Rosen summed it up as "the TV guys won."
In the wake of the news, several observers expressed their frustration: Media consultant Mark Potts ripped Allbritton for not allowing the site breathing room to innovate, and media analyst Janet Coats held it up as an example of old media's resistance to change. Terry Heaton and Lost Remote's Cory Bergman used the episode to talk about the tensions involved when TV stations are affiliated with online media efforts, Glucophage Price.
Reading roundup: There's still quite a bit to get to, but I'll run through it quickly:
— Re Wikileaks: New York Times executive editor Bill Keller edged toward defining WikiLeaks as something a lot like journalism, The Nation's Greg Mitchell explained why the mainstream media is skeptical of WikiLeaks, the Personal Democracy Forum's Micah Sifry and NYU prof Clay Shirky gave some reasons for WikiLeaks' revolutionary nature, and at The Guardian, Evgeny Morozov argued that WikiLeaks can't continue much longer in its current form.
— Yahoo announced a move toward more personal content, particularly tablet-based. The New York Times explained why.
— At the National Sports Journalism Center, Jason Fry wrote a wonderful piece talking about how much less valuable scoops have become in a commoditized news world, and what journalists should do as a result. Craig Calcaterra of the baseball blog Hardball Talk expanded on the idea, offering a vision for the role of bloggers and reporters in a commodity-news environment.
— Two pieces to chew on this weekend, one short and one long: Dave Winer's plea to news organizations to join their communities online, and The New Yorker's Adam Gopnik's musings on the Internet and our interior lives.
Similar posts: Glucophage Mg. Retin A For Sale. Flagyl Over The Counter. Retin A mg. Discount Cipro. Buy Zoloft online cod.
Trackbacks from: Glucophage Price. Glucophage Price. Glucophage Price. Where can i find Glucophage online. Glucophage natural. Glucophage samples.